Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alfa-2b”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00006325
What this trial is testing

Safety, Tolerability, and Anti-HIV Activity of PEG-Intron in HIV-Positive Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 54
Not applicableLooking for participantsNCT06743035
What this trial is testing

Ropeginterferon Alfa-2b in Patients With Polycythemia Vera (PV) Without Symptomatic Splenomegaly

Who this might be right for
Polycythemia Vera
iOMEDICO AG 200
Large-scale testing (Phase 3)Active Not RecruitingNCT04285086
What this trial is testing

Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance

Who this might be right for
Essential Thrombocythemia
PharmaEssentia 174
Testing effectiveness (Phase 2)UnknownNCT04988815
What this trial is testing

Ropeginterferon Alfa 2b for Early Myelofibrosis

Who this might be right for
Primary Myelofibrosis, Prefibrotic StageMyelofibrosis
The University of Hong Kong 50
Testing effectiveness (Phase 2)Study completedNCT00030849
What this trial is testing

Bexarotene and Interferon Alfa in Treating Patients With Cutaneous T-Cell Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Study completedNCT00002556
What this trial is testing

Combination Chemotherapy With or Without High Dose Cyclophosphamide and Recombinant Interferon Alfa-2b in Treating Patients With Previously Untreated Stage I-III Multiple Myeloma

Who this might be right for
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
National Cancer Institute (NCI) 312
Large-scale testing (Phase 3)Study completedNCT00248339
What this trial is testing

Trial of Peg-interferon Plus Epoetin-alfa for Treatment of Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C
Virginia Commonwealth University 150
Not applicableNot Yet RecruitingNCT07120750
What this trial is testing

Post-Radical Treatment Antiviral Strategies in HBV-Related Liver Cancer: Impact on Tumor Prognosis

Who this might be right for
Hepatocellular Carcinoma (HCC)Chronic Hepatitis B
Shenzhen Third People's Hospital 332
Large-scale testing (Phase 3)Study completedNCT05770466
What this trial is testing

Clinical Study for the Efficacy and Safety of Ropeginterferon Alfa-2b in Moderate COVID19.

Who this might be right for
COVID-19
National Taiwan University Hospital 134
Testing effectiveness (Phase 2)Study completedNCT02332473
What this trial is testing

A Prospective Study of Combination of Peginterferon Alfa-2b (40kD, Y-shape) and GM-CSF in Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Xiamen Amoytop Biotech Co., Ltd. 110
Early research (Phase 1)Study completedNCT00001035
What this trial is testing

The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV Infections

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 10
Not applicableNot Yet RecruitingNCT07438093
What this trial is testing

Safety, Tolerability, and Preliminary Efficacy of Peginterferon α-2b in Combination With an Anti-PD-1 Antibody in Patients With Advanced or Metastatic Malignant Solid Tumors

Who this might be right for
Advanced Solid Tumors
The First Affiliated Hospital of Xiamen University 60
Testing effectiveness (Phase 2)Study completedNCT01143662
What this trial is testing

Efficacy and Safety of Ypeginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Xiamen Amoytop Biotech Co., Ltd. 205
Testing effectiveness (Phase 2)WithdrawnNCT00963664
What this trial is testing

Evaluation of Interferon-Lovastatin Therapy for Malignant Melanoma

Who this might be right for
MelanomaMalignant Melanoma
NeoPlas Innovation 250
Large-scale testing (Phase 3)Ended earlyNCT00686881
What this trial is testing

Efficacy of Peginterferon Alfa-2b (SCH 054031) vs Glycyrrhizin in Interferon (IFN)-Treated Patients With Chronic Hepatitis C and F2/F3 Liver Fibrosis (P04773)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 261
Not applicableUnknownNCT05490836
What this trial is testing

Functional Cure Rate of Peg-IFNα-2b Combined With TAF in HBeAg Negative CHB Patients

Who this might be right for
Chronic Hepatitis B
Huashan Hospital 200
Not applicableStudy completedNCT00015652
What this trial is testing

Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV Coinfection

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 24
Large-scale testing (Phase 3)UnknownNCT02327416
What this trial is testing

A Prospective Clinical Trial in Chronic Hepatitis B Patients NAs (Nucleotides or Nucleosides) Experienced (Anchor Study)

Who this might be right for
Hepatitis B, Chronic
Tongji Hospital 300
Not applicableStudy completedNCT00724464
What this trial is testing

Efficacy of PegIntron (Peginterferon Alfa-2b) and Rebetol (Ribavirin) in Treatment-naïve Subjects With Chronic Hepatitis C in Clinical Practice in Greece (Study P05209)

Who this might be right for
Hepatitis C, ChronicHepatitis C
Merck Sharp & Dohme LLC 332
Post-approval studies (Phase 4)UnknownNCT02973646
What this trial is testing

Peginterferon Alfa-2b Treatment in HBeAg(+) Chronic Hepatitis b Patients Based on Interferon Gene Mutation and Receptor Detection

Who this might be right for
Chronic Hepatitis b
Third Affiliated Hospital, Sun Yat-Sen University 100
Next Page